Cargando…
What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis
BACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP). METHODS: A total of 91 patients with ABP who were treated at Trakya...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644090/ https://www.ncbi.nlm.nih.gov/pubmed/37791437 http://dx.doi.org/10.14744/tjtes.2023.06486 |
_version_ | 1785147198355275776 |
---|---|
author | Türkyılmaz, Zeliha Demirel, Tuğrul Cakcak, İbrahim Ethem Aytin, Yusuf Emre |
author_facet | Türkyılmaz, Zeliha Demirel, Tuğrul Cakcak, İbrahim Ethem Aytin, Yusuf Emre |
author_sort | Türkyılmaz, Zeliha |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP). METHODS: A total of 91 patients with ABP who were treated at Trakya University Faculty of Medicine between March 15, 2019 and March 15, 2021 were retrospectively recruited. Patients were classified as pre-COVID and COVID-era patients. The comorbidity markers, data from laboratory tests, inflammatory markers, and radiological examinations were evaluated. Length of stay, need for an intensive care unit, morbidity, mortality, recurrent ABP, and definitive treatment rates were evaluated, and the data of the two periods were compared. RESULTS: Two groups of patients, 57 in the pre-COVID period and 34 in the COVID period, were included in the study. We found that ABP admissions decreased significantly during periods of increased national COVID-19 diagnoses. Type 2 diabetes mellitus was significantly higher in the COVID period patients (P=0.044), and COVID patients had significantly higher total (P=0.004), direct bilirubin (P=0.007), and lipases (P<0.001). The cholecystectomy rate after an attack decreased from 26% in the pre-COVID period to 15.6% during COVID. CONCLUSION: COVID strikingly reduced the admissions of ABP patients in the early stages of the disease to hospitals, leading to inevitable admissions in advanced severity. Moreover, a significant increase was detected in the recurrence rates of ABP. This can be explained by the reduction in cholecystectomy performed. |
format | Online Article Text |
id | pubmed-10644090 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Kare Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-106440902023-11-15 What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis Türkyılmaz, Zeliha Demirel, Tuğrul Cakcak, İbrahim Ethem Aytin, Yusuf Emre Ulus Travma Acil Cerrahi Derg Original Article BACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP). METHODS: A total of 91 patients with ABP who were treated at Trakya University Faculty of Medicine between March 15, 2019 and March 15, 2021 were retrospectively recruited. Patients were classified as pre-COVID and COVID-era patients. The comorbidity markers, data from laboratory tests, inflammatory markers, and radiological examinations were evaluated. Length of stay, need for an intensive care unit, morbidity, mortality, recurrent ABP, and definitive treatment rates were evaluated, and the data of the two periods were compared. RESULTS: Two groups of patients, 57 in the pre-COVID period and 34 in the COVID period, were included in the study. We found that ABP admissions decreased significantly during periods of increased national COVID-19 diagnoses. Type 2 diabetes mellitus was significantly higher in the COVID period patients (P=0.044), and COVID patients had significantly higher total (P=0.004), direct bilirubin (P=0.007), and lipases (P<0.001). The cholecystectomy rate after an attack decreased from 26% in the pre-COVID period to 15.6% during COVID. CONCLUSION: COVID strikingly reduced the admissions of ABP patients in the early stages of the disease to hospitals, leading to inevitable admissions in advanced severity. Moreover, a significant increase was detected in the recurrence rates of ABP. This can be explained by the reduction in cholecystectomy performed. Kare Publishing 2023-09-08 /pmc/articles/PMC10644090/ /pubmed/37791437 http://dx.doi.org/10.14744/tjtes.2023.06486 Text en Copyright © 2023 Turkish Journal of Trauma and Emergency Surgery https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Original Article Türkyılmaz, Zeliha Demirel, Tuğrul Cakcak, İbrahim Ethem Aytin, Yusuf Emre What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis |
title | What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis |
title_full | What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis |
title_fullStr | What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis |
title_full_unstemmed | What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis |
title_short | What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis |
title_sort | what has changed? the impact of the covid-19 pandemic on the management of acute biliary pancreatitis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644090/ https://www.ncbi.nlm.nih.gov/pubmed/37791437 http://dx.doi.org/10.14744/tjtes.2023.06486 |
work_keys_str_mv | AT turkyılmazzeliha whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis AT demireltugrul whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis AT cakcakibrahimethem whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis AT aytinyusufemre whathaschangedtheimpactofthecovid19pandemiconthemanagementofacutebiliarypancreatitis |